TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance

Thali, 2011, Tetraspanin functions during HIV-1 and influenza virus replication, Biochem. Soc. Trans., 39, 529, 10.1042/BST0390529 Farquhar, 2011, Hepatitis C virus entry and the tetraspanin CD81, Biochem. Soc. Trans., 39, 532, 10.1042/BST0390532 Silvie, 2006, Cholesterol contributes to the organization of tetraspanin-enriched microdomains and to CD81-dependent infection by malaria sporozoites, J. Cell Sci., 119, 1992, 10.1242/jcs.02911 McLaughlin, 2016, Identification of Tetraspanin-7 as a target of autoantibodies in type 1 diabetes, Diabetes, 65, 1690, 10.2337/db15-1058 Yang, 2016, Tetraspanins: spanning from solid tumors to hematologic malignancies, Exp. Hematol., 44, 322, 10.1016/j.exphem.2016.02.006 Longo, 2001, Regulatory role of tetraspanin CD9 in tumor–endothelial cell interaction during transendothelial invasion of melanoma cells, Blood, 98, 3717, 10.1182/blood.V98.13.3717 Yánez-Mó, 2001, Tetraspanins and intercellular interactions, Microcirculation (New York, N.Y. : 1994), 8, 153, 10.1111/j.1549-8719.2001.tb00166.x Min, 2006, Structural basis for tetraspanin functions as revealed by the cryo-EM structure of uroplakin complexes at 6-Å resolution, J. Cell Biol., 173, 975, 10.1083/jcb.200602086 Kitadokoro, 2001, CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs, EMBO J., 20, 12, 10.1093/emboj/20.1.12 van Deventer, 2017, Molecular interactions shaping the tetraspanin web, Biochem. Soc. Trans., 45, 741, 10.1042/BST20160284 Florin, 2018, Tetraspanin assemblies in virus infection, Front. Immunol., 9, 10.3389/fimmu.2018.01140 Hemler, 2005, Tetraspanin functions and associated microdomains, Nat. Rev. Mol. Cell Biol., 6, 801, 10.1038/nrm1736 Shoham, 2006, Building of the tetraspanin web: distinct structural domains of CD81 function in different cellular compartments, Mol. Cell. Biol., 26, 1373, 10.1128/MCB.26.4.1373-1385.2006 Seigneuret, 2001, Structure of the tetraspanin Main extracellular domain, J. Biol. Chem., 276, 40055, 10.1074/jbc.M105557200 Kovalenko, 2005, Structural organization and interactions of transmembrane domains in tetraspanin proteins, BMC Struct. Biol., 5, 11, 10.1186/1472-6807-5-11 Stipp, 2003, Functional domains in tetraspanin proteins, Trends Biochem. Sci., 28, 106, 10.1016/S0968-0004(02)00014-2 Termini, 2017, Tetraspanins function as regulators of cellular signaling, Front. Cell Dev. Biol., 5, 10.3389/fcell.2017.00034 Levy, 2005, protein-protein interactions in the tetraspanin web, Physiology, 20, 218, 10.1152/physiol.00015.2005 Bonnet, 2019, Targeting the tetraspanins with monoclonal antibodies in oncology: focus on Tspan8/Co-029, Cancers, 11, 179, 10.3390/cancers11020179 Harrison, 2021, Regulation of ADAM10 by the TspanC8 family of tetraspanins and their therapeutic potential, Int. J. Mol. Sci., 22, 6707, 10.3390/ijms22136707 Rubinstein, 1996, CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins, Eur. J. Immunol., 26, 2657, 10.1002/eji.1830261117 Berditchevski, 2001, Analysis of the CD151·α3β1 integrin and CD151·Tetraspanin interactions by mutagenesis, J. Biol. Chem., 276, 41165, 10.1074/jbc.M104041200 Mazurov, 2013, Tetraspanin protein CD9 interacts with metalloprotease CD10 and enhances its release via exosomes, FEBS J., 280, 1200, 10.1111/febs.12110 Shatz, 2019, ATG9 raises the BAR for PI4P in autophagy, J. Cell Biol., 218, 1432, 10.1083/jcb.201904063 Berditchevski, 2001, Analysis of the CD151 α3β1 integrin and CD151 tetraspanin interactions by mutagenesis, J. Biol. Chem., 276, 41165, 10.1074/jbc.M104041200 Detchokul, 2014, Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies, Br. J. Pharmacol., 171, 5462, 10.1111/bph.12260 Gesierich, 2005, Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility, Clin. Cancer Res., 11, 2840, 10.1158/1078-0432.CCR-04-1935 Lazo, 2007, Functional implications of tetraspanin proteins in cancer biology, Cancer Sci., 98, 1666, 10.1111/j.1349-7006.2007.00584.x Li, 2020, MGAT3-mediated glycosylation of tetraspanin CD82 at asparagine 157 suppresses ovarian cancer metastasis by inhibiting the integrin signaling pathway, Theranostics, 10, 6467, 10.7150/thno.43865 Mhawech, 2004, Motility-related protein-1 (MRP-1/CD9) expression can predict disease-free survival in patients with squamous cell carcinoma of the head and neck, Br. J. Cancer, 90, 471, 10.1038/sj.bjc.6601542 Ivaska, 2002, PKCepsilon controls the traffic of beta1 integrins in motile cells, EMBO J., 21, 3608, 10.1093/emboj/cdf371 Zhang, 2001, Transmembrane-4 superfamily proteins associate with activated protein kinase C (PKC) and link PKC to specific β1 integrins, J. Biol. Chem., 276, 25005, 10.1074/jbc.M102156200 Schooley, 2012, β1 integrin is required for anchorage-independent growth and invasion of tumor cells in a context dependent manner, Cancer Lett., 316, 157, 10.1016/j.canlet.2011.10.032 Cagnet, 2014, Signaling events mediated by α3β1 integrin are essential for mammary tumorigenesis, Oncogene, 33, 4286, 10.1038/onc.2013.391 Eke, 2012, β1 Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy, J. Clin. Investig., 122, 1529, 10.1172/JCI61350 Hwang, 2019, Integrin-independent support of cancer drug resistance by tetraspanin CD151, Cell. Mol. Life Sci., 76, 1595, 10.1007/s00018-019-03014-7 Palmer, 2014, Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression, Cancer Res., 74, 173, 10.1158/0008-5472.CAN-13-0275 Yauch, 2000, Specific interactions among transmembrane 4 superfamily (TM4SF) proteins and phosphoinositide 4-kinase, Biochem. J., 351, 629, 10.1042/bj3510629 Levy, 2014, Function of the tetraspanin molecule CD81 in B and T cells, Immunol. Res., 58, 179, 10.1007/s12026-014-8490-7 Todd, 1996, CD81 expressed on human thymocytes mediates integrin activation and interleukin 2-dependent proliferation, J. Exp. Med., 184, 2055, 10.1084/jem.184.5.2055 Umeda, 2019, Crystallization of the human tetraspanin protein CD9, Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun., 75, 254, 10.1107/S2053230X1801840X Yang, 2020, Open conformation of tetraspanins shapes interaction partner networks on cell membranes, EMBO J., 39, 10.15252/embj.2020105246 Lipper, 2021, Crystal structure of the Tspan15 LEL domain reveals a conserved ADAM10 binding site, Structure Frauman., 2010, The migration and invasion of human prostate cancer cell lines involves CD151 expression, Oncol. Rep., 24, 10.3892/or_00001022 Tardif, 2005, Tetraspanin CD81 provides a costimulatory signal resulting in increased human immunodeficiency virus type 1 gene expression in primary CD4+ T lymphocytes through NF-κB, NFAT, and AP-1 transduction pathways, J. Virol., 79, 4316, 10.1128/JVI.79.7.4316-4328.2005 Tiwari-Woodruff, 2001, OSP/claudin-11 forms a complex with a novel member of the tetraspanin super family and β1 integrin and regulates proliferation and migration of oligodendrocytes, J. Cell Biol., 153, 295, 10.1083/jcb.153.2.295 Otsubo, 2014, TSPAN2 is involved in cell invasion and motility during lung cancer progression, Cell Rep., 7, 527, 10.1016/j.celrep.2014.03.027 Jaiswal, 2018, hTERT promotes tumor progression by enhancing TSPAN13 expression in osteosarcoma cells, Mol. Carcinog., 57, 1038, 10.1002/mc.22824 Testa, 1999, Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis, Cancer Res., 59, 3812 Voss, 2011, Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer, Br. J. Cancer, 104, 1611, 10.1038/bjc.2011.80 Ke, 2009, Role of overexpression of CD151 and/or c-met in predicting prognosis of hepatocellular carcinoma, Hepatology, 49, 491, 10.1002/hep.22639 Romanska, 2015, Expression of CD151/Tspan24 and integrin alpha 3 complex in aid of prognostication of HER2-negative high-grade ductal carcinoma in situ, Int. J. Clin. Exp. Pathol., 8, 9471 Yang, 2008, CD151 accelerates breast cancer by regulating α 6 integrin function, signaling, and molecular organization, Cancer Res., 68, 3204, 10.1158/0008-5472.CAN-07-2949 Zhu, 2021, CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer, Journal of Experimental & Clinical Cancer Research, 40, 1, 10.1186/s13046-021-01998-4 Nishiuchi, 2005, Potentiation of the ligand-binding activity of integrin 3 1 via association with tetraspanin CD151, Proc. Natl. Acad. Sci., 102, 1939, 10.1073/pnas.0409493102 Li, 2021, Proteomic landscape of exosomes reveals the functional contributions of CD151 in triple-negative breast cancer, Mol. Cell. Proteomics, 20, 10.1016/j.mcpro.2021.100121 Liu, 2021, CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia, Stem Cell Res. Ther., 12, 10.1186/s13287-021-02155-6 Ullah, 2019, Mesenchymal stem cells confer chemoresistance in breast cancer via a CD9 dependent mechanism, Oncotarget, 10, 3435, 10.18632/oncotarget.26952 Kohmo, 2010, Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer, Cancer Res., 70, 8025, 10.1158/0008-5472.CAN-10-0996 Shi, 2000, The tetraspanin Cd9 associates with transmembrane TGF-α and regulates TGF-α–Induced egf receptor activation and cell proliferation, J. Cell Biol., 148, 591, 10.1083/jcb.148.3.591 Quagliano, 2020, CD81 knockout promotes chemosensitivity and disrupts in vivo homing and engraftment in acute lymphoblastic leukemia, Blood Adv., 4, 4393, 10.1182/bloodadvances.2020001592 Boyer, 2016, Tetraspanin CD81 is an adverse prognostic marker in acute myeloid leukemia, Oncotarget, 7, 62377, 10.18632/oncotarget.11481 Vences-Catalán, 2021, Targeting the tetraspanin CD81 reduces cancer invasion and metastasis, Proc. Natl. Acad. Sci., 118, 10.1073/pnas.2018961118 Zheng, 2021, CD81 enhances radioresistance of glioblastoma by promoting nuclear translocation of Rad51, Cancers, 13, 1998, 10.3390/cancers13091998 Betrian, 2016, Idelalisib improves CD37 antibody BI 836826 cytotoxicity against chemo-resistant /relapse-initiating CLL cells: a rationale for combination treatment, Blood Cancer Journal, 6, 10.1038/bcj.2016.106 Tominaga, 2014, RPN2-mediated glycosylation of tetraspanin CD63 regulates breast cancer cell malignancy, Mol. Cancer, 13, 134, 10.1186/1476-4598-13-134 Sun, 2020, LncRNA KCNQ1OT1 contributes to the progression and chemoresistance in acute myeloid leukemia by modulating Tspan3 through suppressing miR-193a-3p, Life Sci., 241, 10.1016/j.lfs.2019.117161 Ye, 2017, TSPAN12 promotes chemoresistance and proliferation of SCLC under the regulation of miR-495, Biochem. Biophys. Res. Commun., 486, 349, 10.1016/j.bbrc.2017.03.044 Zhu, 2019, TSPAN8 promotes cancer cell stemness via activation of sonic hedgehog signaling, Nat. Commun., 10, 2863, 10.1038/s41467-019-10739-3 Nishioka, 2014, CD82 regulates STAT5/IL-10 and supports survival of acute myelogenous leukemia cells, Int. J. Cancer, 134, 55, 10.1002/ijc.28348 Hu, 2021, CD63 acts as a functional marker in maintaining hematopoietic stem cell quiescence through supporting TGFβ signaling in mice, Cell Death Differ. Floren, 2020, Tetraspanin CD82 drives acute myeloid leukemia chemoresistance by modulating protein kinase C alpha and β1 integrin activation, Oncogene, 39, 3910, 10.1038/s41388-020-1261-0 Ordas, 2021, Mechanical control of cell migration by the metastasis suppressor tetraspanin CD82/KAI1, Cells, 10, 1545, 10.3390/cells10061545 Dong, 1995, KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2, Science, 268, 884, 10.1126/science.7754374 Zhang, 2003, EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells, Cancer Res., 63, 2665 Trusolino, 2002, Scatter-factor and semaphorin receptors: cell signalling for invasive growth, Nat. Rev. Cancer, 2, 289, 10.1038/nrc779 Kolesnikova, 2004, EWI-2 modulates lymphocyte integrin α4β1 functions, Blood, 103, 3013, 10.1182/blood-2003-07-2201 Kropshofer, 2002, Tetraspan microdomains distinct from lipid rafts enrich select peptide–MHC class II complexes, Nat. Immunol., 3, 61, 10.1038/ni750 Stipp, 2001, EWI-2 is a major CD9 and CD81 partner and member of a novel ig protein subfamily, J. Biol. Chem., 276, 40545, 10.1074/jbc.M107338200 Tian, 2018, Silencing Tspan1 inhibits migration and invasion, and induces the apoptosis of human pancreatic cancer cells, Mol. Med. Rep. Wang, 2018, Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling, J. Exp. Clin. Cancer Res., 37, 300, 10.1186/s13046-018-0969-y Nabokina, 2011, Tspan-1 interacts with the thiamine transporter-1 in human intestinal epithelial cells and modulates its stability, Am. J. Physiol. Gastrointest. Liver Physiol., 301, 808, 10.1152/ajpgi.00269.2011 Principe, 2013, In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine, Proteomics, 13, 1667, 10.1002/pmic.201200561 Gonzales, 2009, Large-scale proteomics and phosphoproteomics of urinary exosomes, J. Am. Soc. Nephrol., 20, 363, 10.1681/ASN.2008040406 Wollscheid, 2002, Identification of a new proliferation-associated protein NET-1/C4.8 characteristic for a subset of high-grade cervical intraepithelial neoplasia and cervical carcinomas, Int. J. Cancer, 99, 771, 10.1002/ijc.10442 Chen, 2012, The effect of NET-1 on the proliferation, migration and endocytosis of the SMMC-7721 HCC cell line, Oncol. Rep., 10.3892/or.2012.1698 Scholz, 2009, Glycosylation of tetraspanin Tspan-1 at four distinct sites promotes its transition through the endoplasmic reticulum, Protein Pept. Lett., 16, 1244, 10.2174/092986609789071234 Munkley, 2017, The cancer-associated cell migration protein TSPAN1 is under control of androgens and its upregulation increases prostate cancer cell migration, Sci. Rep., 7, 5249, 10.1038/s41598-017-05489-5 Park, 2019, GENT2: an updated gene expression database for normal and tumor tissues, BMC Med. Genet., 12, 101 Lu, 2015, TSPAN1 functions as an oncogene in gastric cancer and is downregulated by miR-573, FEBS Lett., 589, 1988, 10.1016/j.febslet.2015.05.044 Hou, 2015, Tetraspanin 1 is involved in survival, proliferation and carcinogenesis of pancreatic cancer, Oncol. Rep., 34, 3068, 10.3892/or.2015.4272 Gu, 2017, Expression and function of tetraspanin 1 in esophageal carcinoma, Oncol. Lett., 10.3892/ol.2017.7028 Duan, 2017, miR-491-3p suppresses the growth and invasion of osteosarcoma cells by targeting TSPAN1, Mol. Med. Rep., 16, 5568, 10.3892/mmr.2017.7256 Chen, 2013, MiR-200a enhances the migrations of A549 and SK-MES-1 cells by regulating the expression of TSPAN1, J. Biosci., 38, 523, 10.1007/s12038-013-9351-6 Chen, 2019, Inhibition of RNA-binding protein Musashi-1 suppresses malignant properties and reverses paclitaxel resistance in ovarian carcinoma, J. Cancer, 10, 1580, 10.7150/jca.27352 Zhang, 2019, TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLCγ, Oncol. Rep. Zhang, 2014, MicroRNA-638 inhibits cell proliferation, invasion and regulates cell cycle by targeting tetraspanin 1 in human colorectal carcinoma, Oncotarget, 5, 12083, 10.18632/oncotarget.2499 Wang, 2012, The effect of NET-1 on the proliferation, migration and endocytosis of the SMMC-7721 HCC cell line, Oncol. Rep., 27, 1944 Shang, 2019, Evaluation of therapeutic effect of targeting nanobubbles conjugated with NET-1 siRNA by shear wave elastography: an in vivo study of hepatocellular carcinoma bearing mice model, Drug Del., 26, 944, 10.1080/10717544.2019.1667450 Li, 2016, Multi-target siRNA: therapeutic strategy for hepatocellular carcinoma, J. Cancer, 7, 1317, 10.7150/jca.15157 Garcia-Mayea, 2020, TSPAN1: a novel protein involved in head and neck squamous cell carcinoma chemoresistance, Cancers, 12, 3269, 10.3390/cancers12113269 Chen, 2010, Suppression of TSPAN1 by RNA interference inhibits proliferation and invasion of colon cancer cells in vitro, Tumori, 96, 744, 10.1177/030089161009600517 Stinnesbeck, 2021, Prognostic role of TSPAN1, KIAA1324 and ESRP1 in prostate cancer, APMIS, 129, 204, 10.1111/apm.13117 Xu, 2016, Decreased TSPAN1 promotes prostate cancer progression and is a marker for early biochemical recurrence after radical prostatectomy, Oncotarget, 7, 63294, 10.18632/oncotarget.11448 Chen, 2009, TSPAN1 protein expression: a significant prognostic indicator for patients with colorectal adenocarcinoma, World J. Gastroenterol., 15, 2270, 10.3748/wjg.15.2270 Zhang, 2019, The transcriptome difference between colorectal tumor and normal tissues revealed by single-cell sequencing, J. Cancer, 10, 5883, 10.7150/jca.32267 Chen, 2008, Clinicopathological significance of overexpression of TSPAN1, Ki67 and CD34 in gastric carcinoma, Tumori, 94, 531, 10.1177/030089160809400415 Ma, 2020, Bionformatics analysis reveals TSPAN1 as a candidate biomarker of progression and prognosis in pancreatic cancer, Bosn. J. Basic Med. Sci., 10.17305/bjbms.2020.5096 Ye, 2021, TSPAN1, TMPRSS4, SDR16C5, and CTSE as novel panel for pancreatic cancer: a bioinformatics analysis and experiments validation, Front. Immunol., 12 Thibodeau, 2015, Gene expression characterization of HPV positive head and neck cancer to predict response to chemoradiation, Head Neck Pathol., 9, 345, 10.1007/s12105-014-0597-6 Hölters, 2013, Tetraspanin 1 promotes invasiveness of cervical cancer cells, Int. J. Oncol., 43, 503, 10.3892/ijo.2013.1980 Li, 2021, Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer, BMC Cancer, 21, 768, 10.1186/s12885-021-08276-8 Shin, 2021, Tetraspanin 1 promotes endometriosis leading to ovarian clear cell carcinoma, Mol. Oncol., 15, 987, 10.1002/1878-0261.12884 Nabokina, 2011, Tspan-1 interacts with the thiamine transporter-1 in human intestinal epithelial cells and modulates its stability. American journal of physiology-gastrointestinal and liver, Physiology, 301, G808 Wang, 2020, TSPAN1 promotes human pancreatic cancer cells proliferation by modulating CDK1 via Akt, bioRxiv Wu, 2021, Tetraspanin 1 (TSPAN1) promotes growth and transferation of breast cancer cells via mediating PI3K/Akt pathway, Bioengineered, 12, 10761, 10.1080/21655979.2021.2003130 Wang, 2020, miR-216a-mediated upregulation of TSPAN1 contributes to pancreatic cancer progression via transcriptional regulation of ITGA2, Am. J. Cancer Res., 10, 1115 Huang, 2008, Midkine promotes tetraspanin–integrin interaction and induces FAK-Stat1α pathway contributing to migration/invasiveness of human head and neck squamous cell carcinoma cells, Biochem. Biophys. Res. Commun., 377, 474, 10.1016/j.bbrc.2008.09.138 Liu, 2019, Tetraspanin 1 as a mediator of fibrosis inhibits EMT process and Smad2/3 and beta-catenin pathway in human pulmonary fibrosis, J. Cell. Mol. Med., 23, 3583, 10.1111/jcmm.14258 Lee, 2018, Discovery of a diagnostic biomarker for colon cancer through proteomic profiling of small extracellular vesicles, BMC Cancer, 18, 1058, 10.1186/s12885-018-4952-y Yang, 2018, Tetraspanin 1 inhibits TNFα-induced apoptosis via NF-κB signaling pathway in alveolar epithelial cells, Inflamm. Res., 67, 951, 10.1007/s00011-018-1189-9 Alvarez-Meythaler, 2020, Autophagy takes center stage as a possible cancer hallmark, Frontiers in Oncology, 10, 10.3389/fonc.2020.586069 Lorente, 2018, The interplay between autophagy and tumorigenesis: exploiting autophagy as a means of anticancer therapy, Biol. Rev., 93, 152, 10.1111/brv.12337 Burman, 2010, Regulation of autophagy by phosphatidylinositol 3-phosphate, FEBS Lett., 584, 1302, 10.1016/j.febslet.2010.01.011 Zhou, 2020, TSPAN1 promotes autophagy flux and mediates cooperation between WNT-CTNNB1 signaling and autophagy via the MIR454-FAM83A-TSPAN1 axis in pancreatic cancer, Autophagy, 1–21 Ferrero Restelli, 2020, Tetraspanin1 promotes NGF signaling by controlling TrkA receptor proteostasis, Cell. Mol. Life Sci., 77, 2217, 10.1007/s00018-019-03282-3 Nishikawa, 2010, The inhibition of autophagy potentiates anti-angiogenic effects of sulforaphane by inducing apoptosis, Angiogenesis, 13, 227, 10.1007/s10456-010-9180-2 Liu, 2011, Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells, Med. Oncol., 28, 105, 10.1007/s12032-009-9397-3 Luo, 2018, 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling, J. Exp. Clin. Cancer Res., 37, 23, 10.1186/s13046-018-0694-6 Li, 2019, Guajadial reverses multidrug resistance by inhibiting ABC transporter expression and suppressing the PI3K/Akt pathway in drug-resistant breast cancer cells, Chem. Biol. Interact., 305, 98, 10.1016/j.cbi.2019.03.032 Ramovs, 2021, Integrin α3β1 is a key regulator of several protumorigenic pathways during skin carcinogenesis, J. Investig. Dermatol., 141, 732, 10.1016/j.jid.2020.07.024 Davis, 2019, PTPRS drives adaptive resistance to MEK/ERK inhibitors through SRC, Oncotarget, 10, 6768, 10.18632/oncotarget.27335 Araujo, 2010, Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumors, Cancer Treat. Rev., 36, 492, 10.1016/j.ctrv.2010.02.015 Sun, 2019, Combined Bcl-2/Src inhibition synergize to deplete stem-like breast cancer cells, Cancer Lett., 457, 40, 10.1016/j.canlet.2019.05.004 Lima, 2020, Targeting the src pathway enhances the efficacy of selective FGFR inhibitors in urothelial cancers with FGFR3 alterations, Int. J. Mol. Sci., 21, 3214, 10.3390/ijms21093214 Mir, 2021, SDCBP modulates stemness and chemoresistance in head and neck squamous cell carcinoma through src activation, Cancers, 13, 4952, 10.3390/cancers13194952 Hermida-Prado, 2019, The differential impact of SRC expression on the prognosis of patients with head and neck squamous cell carcinoma, Cancers, 11, 1644, 10.3390/cancers11111644 Ke, 2016, C-src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC, Oncotarget, 7, 28340, 10.18632/oncotarget.8634 Martellucci, 2020, Src family kinases as therapeutic targets in advanced solid tumors: what we have learned so far, Cancers, 12, 1448, 10.3390/cancers12061448 Aleshin, 2010, SRC: a century of science brought to the clinic, Neoplasia, 12, 599, 10.1593/neo.10328 Lu, 2020, Delivery of TSPAN1 siRNA by novel Th17 targeted cationic liposomes for gastric cancer intervention, J. Pharm. Sci., 109, 2854, 10.1016/j.xphs.2020.05.018 Wu, 2021, Quantitative proteomics analysis of FFPE tumor samples reveals the influences of NET-1 siRNA nanoparticles and sonodynamic therapy on tetraspanin protein involved in HCC, Front. Mol. Biosci., 8, 10.3389/fmolb.2021.678444 Neri, 2018, DNA-encoded chemical libraries: a selection system based on endowing organic compounds with amplifiable information, Annu. Rev. Biochem., 87, 479, 10.1146/annurev-biochem-062917-012550